Patient Engagement Platforms Help Pharma Companies Maintain Brand Value Post-Patent Expiration

Drug Patent Watch identifies patient-centric strategies that pharmaceutical companies can use to maintain brand value following patent expiration. The company suggests several approaches, including personalized medicine and patient engagement platforms. These strategies can help companies navigate the post-patent landscape and maintain a strong brand presence. Drug Patent Watch recommends that companies leverage real-world evidence to inform their brand strategy. They also suggest that companies develop targeted patient support programs to drive adherence and loyalty. In addition, Drug Patent Watch states that companies can harness the power of digital health to reach and engage with patients. More information can be found on the Drug Patent Watch website.

Newsflash | Powered by GeneOnline AI
Date: April 15, 2025

Related posts:

VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments Generic Drug Demand Soars in Emerging Markets Amid Growing Healthcare Needs Analysis: CDMO Partnerships Offer Pharmaceutical Firms Faster Market Entry and Cost Reduction in Drug Development Meribel Pharma Solutions Launches as CDMO with Ten Manufacturing Sites Across Europe.

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後